Litcius/Paper detail

Inhibition of CD82 improves colitis by increasing NLRP3 deubiquitination by BRCC3

Jae‐Sung Kim, Hyo Keun Kim, Joongho Lee, Sein Jang, Euni Cho, Seok‐Jun Mun, Seokhyun Yoon, Chul‐Su Yang

2023Cellular and Molecular Immunology22 citationsDOIOpen Access PDF

Topics & Concepts

InflammasomeColitisIn vivoChemistryCancer researchCell biologyImmunologyBiologyInflammationBiotechnologyInflammasome and immune disordersImmune Response and InflammationGalectins and Cancer Biology
Inhibition of CD82 improves colitis by increasing NLRP3 deubiquitination by BRCC3 | Litcius